تعداد نشریات | 20 |
تعداد شمارهها | 1,149 |
تعداد مقالات | 10,518 |
تعداد مشاهده مقاله | 45,416,255 |
تعداد دریافت فایل اصل مقاله | 11,292,111 |
Evaluation of an Immunomodulator Drug as a Radioprotectant on Human Peripheral Blood Lymphocytes In Vitro | ||
Middle East Journal of Cancer | ||
مقاله 6، دوره 9، شماره 1، فروردین 2018، صفحه 35-40 اصل مقاله (801.58 K) | ||
نوع مقاله: Original Article(s) | ||
شناسه دیجیتال (DOI): 10.30476/mejc.2018.42102 | ||
نویسندگان | ||
Zahra Sattarpour1؛ Bahzad Baradaran1؛ Alireza Farajollahi2؛ Mohammad Asghari Jafarabadi3؛ Vahid Khazeh1؛ Jalil Pirayesh Islamian* 2 | ||
1Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran | ||
2Department of Medical Physics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran | ||
3Department of Statistics and Epidemiology, Faculty of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran | ||
چکیده | ||
Background: IMOD™, a selenium enriched extract of the plants Tanacetum vulgare, Urtica dioica, and Rosa canina, has an excellent effect on oxidative stress. In this study, we investigated the radioprotective effects of this immunomodulatory drug on human peripheral blood lymphocytes.Methods: Peripheral blood samples obtained from venipuncture of the brachial vein were treated with IMOD™ (5, 10, 15, 20 μl) for 30 min and Cobalt 60 γ-rays (0.25, 0.5, 1, 2 Gy) as the test groups and cultured with the control. We used the micronuclei assay, cell death detection, and cell toxicity assay to analyze the treatment effects.Results: The frequency of micronuclei were 1.66 (0 Gy), 5.33 (0.25 Gy), 9.67 (0.5 Gy), 17.67 (1 Gy), and 23.67 (2 Gy) in the irradiated lymphocytes (P<0.001). The percentage of micronuclei frequency reduced to 20%, 26.83%, 37.68%, 16%, and 20.47% with IMOD™. Apoptosis and necrosis decreased significantly in the IMOD™ treated groups (P<0.05).Conclusion: IMOD™ may protect these cells against ionizing radiation. | ||
آمار تعداد مشاهده مقاله: 3,451 تعداد دریافت فایل اصل مقاله: 1,195 |